FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 2172994 · Received July 23, 2011

Report

Report Number
2124215-2011-10437
Event Type
Malfunction
Date Received
July 23, 2011
Date of Event
June 10, 2011
Report Date
July 12, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P960040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

ALL AVAILABLE INFORMATION INDICATES THAT THIS PRODUCT REMAINS IN SERVICE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) EXHIBITED HIGH OUT OF RANGE SHOCK IMPEDANCES OF GREATER THAN 125 OHMS. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS PROVIDED THAT THE HIGH SHOCK IMPEDANCE WAS ISOLATED; SUBSEQUENT TRANSMISSIONS REVEALED THE SHOCK IMPEDANCE WAS BACK WITHIN NORMAL RANGE. THE PATIENT WILL CONTINUE TO BE FOLLOWED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 75 YR (B)(4)| (B)(4)| (B)(4)| (B)(4)| (B)(4)